1. Home
  2. OLMA vs MLP Comparison

OLMA vs MLP Comparison

Compare OLMA & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • MLP
  • Stock Information
  • Founded
  • OLMA 2006
  • MLP 1909
  • Country
  • OLMA United States
  • MLP United States
  • Employees
  • OLMA N/A
  • MLP N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • MLP Real Estate
  • Sector
  • OLMA Health Care
  • MLP Finance
  • Exchange
  • OLMA Nasdaq
  • MLP Nasdaq
  • Market Cap
  • OLMA 289.0M
  • MLP 312.9M
  • IPO Year
  • OLMA 2020
  • MLP 1972
  • Fundamental
  • Price
  • OLMA $4.42
  • MLP $15.00
  • Analyst Decision
  • OLMA Strong Buy
  • MLP
  • Analyst Count
  • OLMA 3
  • MLP 0
  • Target Price
  • OLMA $27.67
  • MLP N/A
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • MLP 20.4K
  • Earning Date
  • OLMA 05-07-2025
  • MLP 05-12-2025
  • Dividend Yield
  • OLMA N/A
  • MLP N/A
  • EPS Growth
  • OLMA N/A
  • MLP N/A
  • EPS
  • OLMA N/A
  • MLP N/A
  • Revenue
  • OLMA N/A
  • MLP $11,565,000.00
  • Revenue This Year
  • OLMA N/A
  • MLP N/A
  • Revenue Next Year
  • OLMA N/A
  • MLP N/A
  • P/E Ratio
  • OLMA N/A
  • MLP N/A
  • Revenue Growth
  • OLMA N/A
  • MLP 24.50
  • 52 Week Low
  • OLMA $2.86
  • MLP $15.00
  • 52 Week High
  • OLMA $16.62
  • MLP $26.46
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 60.78
  • MLP 29.88
  • Support Level
  • OLMA $2.96
  • MLP $14.37
  • Resistance Level
  • OLMA $3.41
  • MLP $16.25
  • Average True Range (ATR)
  • OLMA 0.35
  • MLP 0.90
  • MACD
  • OLMA 0.16
  • MLP -0.12
  • Stochastic Oscillator
  • OLMA 98.73
  • MLP 16.94

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

Share on Social Networks: